Article

Oncologist Beth Overmoyer on Inflammatory Breast Cancer

Beth Overmoyer, a breast oncologist at the Susan F. Smith Center for Women's Cancer's at Dana-Farber in Boston, provides a brief overview of inflammatory breast cancer.

Beth Overmoyer, a breast oncologist at the Susan F. Smith Center for Women’s Cancer’s at Dana-Farber in Boston, provides a brief overview of women likely to be diagnosed with inflammatory breast cancer, and the need for a better understanding of the disease.

Inflammatory breast cancer is found in both premenopausal and postmenopausal women. Overmoyer says the biology of inflammatory breast cancer differs from other types of breast cancer. Clinical presentations of the disease are often missed by both practitioners and patients. A poster session at the 2014 San Antonio Breast Cancer Symposium provided attendees with the opportunity to explore inflammatory breast cancer, its epidemiology and its outcomes.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Waldenstrom macroglobulinemia is often slow growing, with high survival but lower quality of life over time, explained researcher Alisha Kimble.
Image of woman.
Image of two doctors and text.
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
image of serzan.
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
Image of two doctors with text.
Image of doctors with text.
Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma
Image of two doctors and text.